[Sinovac and Butantan Join Efforts to Advance the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III Beijing (China), Sao Paulo, (Brazil), June 11th, 2020 Science Sinovac has made significant progress in the development of CoronaVac. Promising preclinical results regarding Coron]
[] [List of Subsidiaries and Variable interest entity Name Jurisdiction of Affiliate Relationship Tarena Hong Kong Limited Hong Kong Wholly-owned subsidiary of Tarena International, Inc. Tarena Technologies Inc. PRC Wholly-owned subsidiary of Tarena International, Inc. Taiwan Tarena Counseling Softwa]
[Sinovac and Butantan Join Efforts to Advance the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III Beijing (China), Sao Paulo, (Brazil), June 11th, 2020 Science Sinovac has made significant progress in the development of CoronaVac. Promising preclinical results regarding Coron]
[China Ceramics Co., Ltd. c/o Jinjiang Hengda Ceramics Co., Ltd. Junbing Industrial Zone, Anhai Jinjiang City, Fujian Province People’s Republic of China June 11, 2020 Division of Corporation Finance Office of Manufacturing 100 F Street, NE Attn: Thomas Jones, Esq. Re: Request for Acceleration China ]
